A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences.
暂无分享,去创建一个
G. Lozanski | M. Karafa | R. Coupland | E. Hsi | B. Pohlman | I. Mirza | John Hill
[1] D. Hochhauser,et al. Non‐Hodgkin's Lymphomas , 2007 .
[2] R B Mann,et al. Criteria for the cytologic subclassification of follicular lymphomas: A Proposed alternative method , 2007, Hematological oncology.
[3] W. Chan,et al. A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival. , 2003, Blood.
[4] E. Haralambieva,et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. , 2003, Blood.
[5] A. Rosenwald,et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. , 2002, Blood.
[6] S. Perkins,et al. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas. , 2001, American journal of clinical pathology.
[7] H. Kantarjian,et al. Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[9] W. Chan,et al. Clinical Significance of the t(14;18) And BCL2 Overexpression in Follicular Large Cell Lymphoma , 2000, Leukemia & lymphoma.
[10] D. Arber,et al. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[11] D. Weisenburger,et al. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] R. Fisher,et al. Follicular lymphomas: do histologic subtypes predict outcome? , 1997, Hematology/oncology clinics of North America.
[13] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[14] S. Horning. Natural history of and therapy for the indolent non-Hodgkin's lymphomas. , 1993, Seminars in oncology.
[15] M. Ladanyi,et al. Cytogenetic analysis of 434 consecutively ascertained specimens of non‐Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment , 1991, Genes, chromosomes & cancer.
[16] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[17] M. Oken,et al. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. , 1987, The New England journal of medicine.
[18] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[19] R. Lukes,et al. Immunologic characterization of human malignant lymphomas , 1974, Cancer.
[20] K. Lennert,et al. Classification of Non-Hodgkin’s Lymphomas , 1974 .
[21] Cdm Fletcher,et al. World Health Organization Classification of Tumours , 2002 .
[22] H. Rappaport,et al. Tumors of the hematopoietic system , 1966 .